Trial Profile
Clinical and Cost Impact of Complete and Incomplete Rotarix Vaccination
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2023
Price :
$35
*
At a glance
- Drugs RIX 4414 (Primary)
- Indications Rotavirus infections
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 13 Mar 2014 According to the ClinicalTrials.gov record, status changed from not yet recruiting to completed.
- 14 Aug 2013 New trial record